Combination Daclizumab/Denileukin Diftitox to Treat Uveitis

NCT00326508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Non-infectious Intermediate and Posterior Uveitis

Interventions

DRUG: Daclizumab

Sponsor

National Eye Institute (NEI)